| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |